The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Tissue sealants serve primarily as a physical barrier to prevent leakage of fluid and/or gas from a surgical incision. Tissue adhesives consist of polymers that form a thin protective film and create a strong adherent bond to hold the edges of wounds on the skin. GlobalData uses proprietary data and analytics to provide a comprehensive report on the tissue sealants and adhesives devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the tissue sealants and adhesives market in New Zealand was Baxter International followed by Cardinal Health, Ethicon, CR Bard, Derma Sciences, B. Braun Melsungen and CryoLife Europa.
Tissue sealants can be used to hold the flaps of internal organs together, to seal the blood vessels in case of injury/surgery or as an adjunct with hemostatic agents. These products are used to seal tissue and prevent leaks (blood, CSF, air, bile). They take the form of liquid sealant, patch embedded with a sealant agent, or flowable paste. Tissue sealants based on their composition can be classified as either synthetic or non-synthetic tissue sealants. The volume of tissue sealant used per procedure varies depending on the type of procedure and formulation. Tissue sealants may be sold in a kit consisting of a delivery device and an activating agent such as thrombin. These delivery devices and activating agents are not tracked under this segment. Tissue Adhesives allow for proper healing of the wound under the film and protects the wound from microbial infections. Tissue adhesives based on their composition can be classified as cyanoacrylate-based tissue adhesives and other cross-linkable polymer-based tissue adhesives. The volume of tissue adhesive used per procedure varies depending on the type of procedure and formulation.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the tissue sealants and adhesives devices market within New Zealand was expected to be over $10m in 2022.
For the latest complete market share analysis of tissue sealants and adhesives device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
